410 related articles for article (PubMed ID: 25811726)
41. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Chang BH; Stork L; Fan G
Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
[TBL] [Abstract][Full Text] [Related]
42. Current management of nasal NK/T-cell lymphoma.
Au WY
Oncology (Williston Park); 2010 Apr; 24(4):352-8. PubMed ID: 20464847
[TBL] [Abstract][Full Text] [Related]
43. Nasal T cell lymphoma: a rare entity.
Kazi M; Ikram M; Junaid M
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S50-1. PubMed ID: 24718007
[TBL] [Abstract][Full Text] [Related]
44. First case of primary intraocular natural killer t-cell lymphoma.
Maruyama K; Kunikata H; Sugita S; Mochizuki M; Ichinohasama R; Nakazawa T
BMC Ophthalmol; 2015 Nov; 15():169. PubMed ID: 26585973
[TBL] [Abstract][Full Text] [Related]
45. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
46. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.
Devins K; Schuster SJ; Caponetti GC; Bogusz AM
Diagn Pathol; 2018 Nov; 13(1):92. PubMed ID: 30470245
[TBL] [Abstract][Full Text] [Related]
47. Extranodal NK/T-cell lymphoma, nasal type, possibly arising from chronic Epstein-Barr virus infection.
Seishima M; Yuge M; Kosugi H; Nagasaka T
Acta Derm Venereol; 2010; 90(1):102-3. PubMed ID: 20107744
[No Abstract] [Full Text] [Related]
48. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
49. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract][Full Text] [Related]
50. Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphoma.
Tsai HJ; Lin SF; Chen CC; Chen TY; Su WC; Hwang WL; Lin JC; Chiou TJ; Kao WY; Chiu CF; Chang YF; Chang JS; Chang MC; Su IJ
Eur J Haematol; 2015 Feb; 94(2):130-7. PubMed ID: 24957163
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus associated extranodal natural killer T cell lymphoma of nasal type mimicking pyogenic osteomyelitis of the proximal humerus.
Wong T; Ko JY; Wang FS; Chen YJ; Ma MC
Chang Gung Med J; 2008; 31(3):314-9. PubMed ID: 18782956
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous EBV-positive γδ T-cell lymphoma vs. extranodal NK/T-cell lymphoma: a case report and literature review.
Yu WW; Hsieh PP; Chuang SS
J Cutan Pathol; 2013 Mar; 40(3):310-6. PubMed ID: 23240992
[TBL] [Abstract][Full Text] [Related]
53. Extranodal NK/T-cell lymphoma, nasal type of the uterine cervix: A case report.
Omori M; Oishi N; Nakazawa T; Nakazawa K; Mitsumori T; Yuminamochi T; Kirito K; Hirata S
Diagn Cytopathol; 2016 May; 44(5):430-3. PubMed ID: 26872300
[TBL] [Abstract][Full Text] [Related]
54. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
[TBL] [Abstract][Full Text] [Related]
55. Primary Central Nervous System Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Colliding with Meningioma.
Yan J; Liu W; Wang X; Zhao S; Gao L; Ye Y; Lei X; Long Y; Ji J; Zhang W
World Neurosurg; 2018 Dec; 120():17-26. PubMed ID: 30144614
[TBL] [Abstract][Full Text] [Related]
56. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
57. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
58. Primary bone natural killer/T cell lymphoma, nasal type without EBV infection: a case report.
Tian C; Wang Y; Zhu L; Yu Y; Zhang Y
Int J Clin Exp Pathol; 2015; 8(11):14836-9. PubMed ID: 26823813
[TBL] [Abstract][Full Text] [Related]
59. Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
Jiang M; Zhang H; Jiang Y; Yang Q; Xie L; Liu W; Zhang W; Ji X; Li P; Chen N; Zhao S; Wang F; Zou L
Cancer; 2012 Jul; 118(13):3294-301. PubMed ID: 22139825
[TBL] [Abstract][Full Text] [Related]
60. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]